Erratum to “Opsonic monoclonal antibodies enhance phagocytic killing activity and clearance of Mycobacterium tuberculosis from blood in a quantitative qPCR mouse model” [Heliyon 5 (9), (September 2019), e02260]
Clara J. Sei, Bong-Akee Shey, Richard F. Schuman, Nimisha Rikhi, Kevin Muema, John D. Rodriguez, Luke T. Daum, P. Bernard Fourie, et al. (9 authors)
Heliyon · 2019-10
Abstract
In the original published version of this article, the subheading for section 2.1, “Mycobacterium smegmatis (SMEG)”, was missing italics. This error was introduced during the typesetting of the article, the publisher apologises for this error. Both the HTML and PDF versions of the article have been updated to correct the error. Opsonic monoclonal antibodies enhance phagocytic killing activity and clearance of Mycobacterium tuberculosis from blood in a quantitative qPCR mouse modelSei et al.HeliyonSeptember 8, 2019In BriefPatients with impaired immunity often have rapid progression of tuberculosis (TB) which can lead to highly lethal Mycobacterium tuberculosis (MTB) sepsis. Opsonic monoclonal antibodies (MABs) directed against MTB that enhance phagocytic killing activity and clearance of MTB from blood may be useful to enhance TB immunity. Full-Text PDF Open Access
MeSH terms
- Opsonin
- Monoclonal antibody
- Mycobacterium tuberculosis
- Phagocytosis
- Immunology
- Antibody
- Tuberculosis
- Microbiology
- Medicine
- Virology
- Biology